Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma.

Gunnarsson, Orvar; Pfanzelter, Nicklas R; Cohen, Roger B; Keefe, Stephen M

Gunnarsson, Orvar; Pfanzelter, Nicklas R; Cohen, Roger B; Keefe, Stephen M.

Afiliação

Gunnarsson O; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Pfanzelter NR; Department of Medicine, Division of Hematology and Oncology, Rush University Medical Center, Chicago, IL, USA.
Cohen RB; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Keefe SM; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Cancer Manag Res ; 7: 65-73, 2015.

Article em En | MEDLINE | ID: mdl-25709499

Palavras-chave

axitinib; drug safety; renal cell carcinoma; side effects

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancer Manag Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google